According to related studies, it was demonstrated that cell proliferation and migration decreased, and the tumor volume was also reduced by 55% in the T24-xenograft in vivo model through the inhibition of rpS6 phosphorylation and subsequent inactivation of the mTOR pathway [142]. The gene discussed is MTOR; the disease is neoplasm.